Index: | S&P 500 | P/E: | 22.98 | EPS (ttm): | 5.15 | Insider Own: | 0.28% | Shs Outstand: | 242.00M | Perf Week: | 0.15% |
Market Cap: | 28.94B | Forward P/E: | 13.63 | EPS next Y: | 8.68 | Insider Trans: | -22.81% | Shs Float: | 241.34M | Perf Month: | -1.71% |
Income(ttm): | 1.26B | PEG: | 1.77 | EPS next Q: | 1.76 | Inst Own: | 88.83% | Short Float: | 1.98% | Perf Quarter: | 5.76% |
Revenue(ttm): | 224.50B | P/S: | 0.13 | EPS this Y: | 3.94% | Inst Trans: | -0.77% | Short Ratio: | 2.27 | Perf Half Y: | 12.76% |
Book/sh: | -13.54 | P/B: | - | EPS next Y: | 10.85% | ROA: | 2.91% | Short Interest: | 4.78M | Perf Year: | 19.33% |
Cash/sh: | 11.72 | P/C: | 10.09 | EPS next 5Y: | 13.00% | ROE: | - | 52W Range: | 93.17 - 126.23 | Perf YTD: | 17.34% |
Dividend Est.: | 2.06 (1.75%) | P/FCF: | 27.27 | EPS past 5Y: | -5.30% | ROI: | 133.26% | 52W High: | -6.30% | Beta: | 0.65 |
Dividend TTM: | 2.01 (1.70%) | Quick Ratio: | 0.50 | Sales past 5Y: | 9.33% | Gross Margin: | 3.26% | 52W Low: | 26.95% | ATR (14): | 2.59 |
Dividend Ex-Date: | Jan 02, 2025 | Current Ratio: | 0.95 | EPS Y/Y TTM: | 738.21% | Oper. Margin: | 0.98% | RSI (14): | 48.39 | Volatility: | 2.09% 2.09% |
Employees: | 48900 | Debt/Eq: | - | Sales Y/Y TTM: | 6.82% | Profit Margin: | 0.56% | Recom: | 2.26 | Target Price: | 133.64 |
Option/Short: | Yes / Yes | LT Debt/Eq: | - | EPS Q/Q: | 8390.00% | Payout: | 58.20% | Rel Volume: | 4.34 | Prev Close: | 117.00 |
Sales Surprise: | 2.72% | EPS Surprise: | 16.13% | Sales Q/Q: | -4.54% | Earnings: | Nov 01 BMO | Avg Volume: | 2.11M | Price: | 118.28 |
SMA20: | -1.68% | SMA50: | 0.85% | SMA200: | 9.75% | Undervalued: 12.99% | Volume: | 9,160,340 | Change: | 1.09% |
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.